<DOC>
	<DOCNO>NCT00930579</DOCNO>
	<brief_summary>The purpose pilot study use pre surgical intervention model evaluate biologic effect metformin woman newly diagnose early invasive breast cancer . Metformin drug commonly use treat patient diabetes . This model use evaluate effect metformin .</brief_summary>
	<brief_title>Metformin Pre-Surgical Pilot Study</brief_title>
	<detailed_description>The purpose pilot study use pre surgical intervention model evaluate biologic effect metformin woman newly diagnose early invasive breast cancer . Metformin biguanide derivative commonly use treat patient diabetes . This model use evaluate effect metformin specific molecular pathway call AMPK/mTOR signal pathway tumor . The effect metformin serum insulin level component insulin resistance syndrome also study .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Histologicallyconfirmed operable invasive breast cancer DCIS undergo core needle biopsy follow surgical excision least 2 week enrollment Body mass index &gt; 25 Age â‰¥ 21 year No prior chemotherapy , radiation therapy , surgery within 6 month study entry Signed informed consent History diabetes mellitus require medical therapy Treatment investigational drug within 6 month study entry Significant renal impairment creatinine &gt; 1.4 mg/dl Other serious intercurrent medical illness</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>